AUSTRALIA'S #1 ONLINE CPD EDUCATION PLATFORM

This module explores the latest evidence-based approach to the management of Parkinson's disease, dystonia and essential tremor, with a focus on the role of deep brain stimulation in the treatment of...
This module explores how to identify risk factors and make a diagnosis of MCI, and outlines the effective development of treatment plans for MCI in primary care.
This second module on ME/CFS provides detail on making a differential diagnosis, the non-core symptoms of ME/CFS, management in specific populations, and the development of a patient-centred treatment plan.
This module explores the role of CGM and Flash GM in providing effective diabetes care, and provides guidance on interpreting glucose profiles and setting personalised targets.
Learn how to take a systematic approach to diagnosis, investigation, referral and ongoing management of oral cavity and oropharyngeal cancers.
This module takes participants though a step-wise model which helps identify patients at risk of osteoporotic fracture, and looks at strategies for prevention and ongoing management.

T2D injectables: 1. Intensifying to first injectable therapy in uncomplicated type 2 diabetes

This education module focuses on a case study of an uncomplicated patient with type 2 diabetes, and the process of intensifying to first injectable therapy. Expert video commentary throughout the module helps step the participant through the decision cycle from the ADA/EASD consensus guidelines for T2D. This module also includes Australian recommendations for patients fasting during Ramadan.

T2D injectables: 2. Intensifying to first injectable therapy in patients with ASCVD risk

In this education module, the participant will work through a case study of a type 2 diabetes patient with ASCVD risk factors. The case study uses the decision cycle from the ADA/EASD consensus guidelines for T2D, and features expert video commentary. The module also discusses patient-related concerns leading to clinical inertia, including useful management decisions when faced with this issue.

T2D injectables: 3. Intensifying to first injectable therapy in patients with established ASCVD

This education module takes a case-study based look at the management of a type 2 diabetes patient with established ASCVD. Featuring expert video commentary, participants will use the decision cycle from the ADA/EASD consensus guidelines for T2D to work through a hypothetical case study. This module also discusses GP-related causes of clinical inertia, as well as additional patient factors such as obesity, low health literacy and diabetes distress.

Rethinking first injectable therapies in type 2 diabetes: A practical approach

This accredited learning module explores how to initiate injectable therapy in a patient with type 2 diabetes who remains above their glycaemic target despite taking dual or triple oral therapy. The activity works through 3 in-depth case-studies: a patient with uncomplicated T2D, a patient with ASCVD risk, and a patient with established ASCVD.

Providing effective eye care and referrals in general practice

Gonzalo Jacome, Senior Staff Clinician, Centre for Eye Health, UNSW discusses how general practitioners can provide effective first-line care for a range of eye conditions. Ways to diagnose eye conditions in a telehealth consultation are explored, as well as the identification of ocular emergencies and coordinating care with optometrists in glaucoma management.

Pages